Home » Gilead Sciences Allows Four Indian Pharmaceutical Companies to Sell HIV Generics
Gilead Sciences Allows Four Indian Pharmaceutical Companies to Sell HIV Generics
California-based Gilead Sciences has allowed four Indian companies to make and sell low-cost versions of three of its new HIV drugs under a first-of-its-kind agreement between an innovator pharmaceutical firm and a United Nations-backed patent-sharing body.
The Economic Times
The Economic Times
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May